Development of a Novel and Robust Pharmacological Model of Okadaic Acid-induced Alzheimer’s Disease in Zebrafish

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|15|1|86-94

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.1, 2016-02, pp. : 86-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological strategies for the prevention of Alzheimer’s disease

By Doraiswamy P Murali   Xiong Glen L  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 1, 2006-01 ,pp. : 1-10

Informa Healthcare

Access to resources Recommend Favorite

Transgenic animal model for Alzheimer’s disease

By  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 729-732

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy in a Rabbit Model of Alzheimer’s Disease

By S. Woodruff-Pak Diana   Shriver Christina   Agelan Alexis   M. Manns Joanne   Coico Richard  

Drug Delivery Letters, Vol. 2, Iss. 1, 2012-03 ,pp. : 14-21

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment Strategies in Alzheimer’s Disease with a Focus on Early Pharmacological Interventions

By Marksteiner J.  

Drugs & Aging, Vol. 21, Iss. 7, 2004-01 ,pp. : 415-426

Adis International

Access to resources Recommend Favorite

NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer’s Disease

By  

Current Drug Discovery Technologies, Vol. 12, Iss. 4, 2015-12 ,pp. : 214-217

Bentham Science Publishers

Access to resources Recommend Favorite